Virologist Beata Halassy says self-treatment worked and was a positive experience - but researchers warn that it is not something others should try. Virologist Beata Halassy says self-treatment worked and was a positive experience - but researchers warn that it is not something others should try.

TAMPA, Fla. - Immunotherapies have improved outcomes of many patients with cancer, including melanoma. But these therapies work for only a subset of patients. Numerous studies are looking at improving responses, including research focusing on enhancing tumor-infiltrating lymphocytes (TILs).

Scientists have created a new powerful "masked" cancer drug. Numerous cancer treatments are notoriously harsh on the body; they assault healthy cells simultaneously with tumor cells and result in a wide range of side effects. The Pritzker School of Molecular Engineering (PME) at the University of C

Researchers uncover a new strategy to avoid cancer immunotherapy side effects. It's not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started experiencing negative side effects during a cancer immunotherapy trial, researchers at La Jolla Institu

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Visit the News Hub Targeted therapy shrank tumors, shows promise in improving survival Huy Mach The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.

Prof Sewell said the 'right people' are now interested in developing the potential new therapy and said progress could now move 'quite fast'. The team says human trials on terminally ill patients could begin as early as November if the new treatment passes further laboratory safety testing.

Stanford researchers made a groundbreaking discovery about brain tumors. The study reports high-grade gliomas form synapses which hijack electrical signals from healthy neurons in the brain, promoting tumor growth. Interrupting the signals with a drug currently used to treat epilepsy reduces the tumor growth in mouse models.